NCT02216422View on ClinicalTrials.gov

A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Hepatitis C Virus (HCV) Infection
Interventions
DRUG

Ombitasvir/Paritaprevir/Ritonavir

Tablet; paritaprevir co-formulated with ritonavir and ombitasvir

DRUG

Dasabuvir

Tablet

DRUG

Ribavirin (RBV)

Tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY